Skip to Content

BMS 200 mg 3631 (Reyataz 200 mg)

Generic Name: atazanavir

Pill with imprint BMS 200 mg 3631 is Blue, Capsule-shape and has been identified as Reyataz 200 mg. It is supplied by Bristol-Myers Squibb.

Reyataz is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Reyataz 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BMS 200 mg 3631

Reyataz 200 mg BMS 200 mg 3631
Reyataz 200 mg BMS 200 mg 3631
Reyataz 200 mg BMS 200 mg 3631
Reyataz 200 mg BMS 200 mg 3631

Reyataz

Generic Name
atazanavir
Imprint
BMS 200 mg 3631
Strength
200 mg
Color
Blue
Size
22.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Protease inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Bristol-Myers Squibb
Inactive Ingredients
lactose monohydrate, magnesium stearate, FD&C Blue No. 2, titanium dioxide, ferric oxide red, ferric oxide yellow, isopropyl alcohol, ammonia, propylene glycol, butyl alcohol, alcohol, ferrosoferric oxide, shellac

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00003-3631
54868-4854 Physicians Total Care Inc. (repackager)
54569-5532 A-S Medication Solutions, LLC (repackager)
35356-0207 Lake Erie Medical and Surgical Supply (repackager)

Get help with Imprint Code FAQs.

Related Images for "BMS 200 mg 3631"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.